Background
The failing heart displays increased glycolytic flux that is not matched by a commensurate increase in glucose oxidation. This mismatch induces increased anaplerotic flux and inefficient glucose metabolism. We previously found adult transgenic mouse hearts expressing the fetal troponin I isoform, (ssTnI) to be protected from ischemia by increased glycolysis. In the present study we investigated the metabolic response of adult mouse hearts expressing ssTnI to chronic pressure overload.
Methods and Results
At 2–3 months of age ssTnI mice or their nontransgenic (NTG) littermates underwent aortic constriction (TAC). TAC induced a 25% increase in NTG heart size but only a 7% increase in ssTnI hearts (P<0.05). NTG TAC developed diastolic dysfunction (65% increased E/A ratio), while the E/A ratio actually decreased in ssTnI TAC. Isolated perfused hearts from NTG TAC mice showed reduced cardiac function and reduced PCr:ATP (16% reduction), but ssTnI TAC hearts maintained cardiac function and energy charge. Contrasting NTG TAC, ssTnI TAC significantly increased glucose oxidation at the expense of palmitate oxidation, preventing the increase in anaplerosis observed in NTG TAC hearts. Elevated glucose oxidation was mediated by a reduction in PDK4 expression, enabling PDH to compete against anaplerotic enzymes for pyruvate carboxylation.
Conclusions
Expression of a single fetal myofilament protein into adulthood in the ssTnI-TG mouse heart induced downregulation of the gene expression response for PDK to pressure overload. The consequence of elevated pyruvate oxidation in ssTnI during TAC reduced anaplerotic flux, ameliorating inefficiencies in glucose oxidation, with energetic and functional protection against cardiac decompensation.